Inactive Instrument

Other languages VICS VANT

Equities

VCKA

KYG9440B1077

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Scilex Holding Company completed the acquisition of Vickers Vantage Corp. I from Vickers Venture Fund VI L.P. and Vickers Venture Fund VI Pte Ltd, managed by Vickers Venture Partners, Shaolin Capital Management LLC, Hudson Bay Capital Management LP and others in a reverse merger transaction.	22-11-09
Vickers Vantage Corp. I Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-04
Vickers Vantage Corp. I Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-12
Sorrento Therapeutics Unit Scilex Plans to Acquire Ancora Medical	22-07-07
Vickers Vantage Corp. I Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16
Vickers Vantage I Extends Time to Complete Business Combination by Three Months	22-04-11
Sorrento Therapeutics Unit Scilex Enters Deal with B Riley Financial for $5 Billion Financing Facility	22-03-25
Sorrento's Scilex Says Semdexa Reduces Pain in Late-Stage Sciatica Trial; Scilex to Merge with Blank Check Firm	22-03-18
Vickers Vantage Corp. I Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-24
Vickers Vantage Corp. I Auditor Raises 'Going Concern' Doubt	22-02-23
Vickers Vantage Corp. I Extends Deadline to Complete SPAC Deal	22-01-07
Sorrento Unit Scilex Plans Business Combination With Blank-Check Firm Vickers Vantage Corp I	21-12-06
Vickers Vantage Corp. I Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-10
Vickers Vantage Corp. I Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-19
Vickers Vantage Corp. I Announces Earnings Results for the Period from February 21, 2020 to December 31, 2020	21-03-31

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer